ARID1B and breast cancer: To further determine the relevance of aberrant accumulation in tumor development, we either overexpressed (OE) or depleted (KO) ARID1B in breast cancer cells and evaluated its impact on cancer cell growth (Figure 2B,C, Figure S4A, Supporting Information).